Search research articles
Contact Us
Filters
Showing results (131-140 of 134) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 134 results.
Journal of Pediatric Urology
|
March 25, 2026
Utility and challenges of flexible and navigable suction ureteral access sheath (FANS) vs. suction mini-PCNL in children: A comparative analysis
Ee Jean Lim, Steffi Kar Kei Yuen, Bhaskar Kumar Somani, et al.
The New England Journal of Medicine
|
November 27, 2024
Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal Cancer
Thierry Andre, Elena Elez, Eric Van Cutsem, et al.
Lancet (London, England)
|
January 28, 2025
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
Thierry André, Elena Elez, Heinz-Josef Lenz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2024
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study
Natasha B Leighl, Hiroaki Akamatsu, Sun Min Lim, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 134) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 134 results.
Journal of Pediatric Urology
|
March 25, 2026
Utility and challenges of flexible and navigable suction ureteral access sheath (FANS) vs. suction mini-PCNL in children: A comparative analysis
Ee Jean Lim, Steffi Kar Kei Yuen, Bhaskar Kumar Somani, et al.
The New England Journal of Medicine
|
November 27, 2024
Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal Cancer
Thierry Andre, Elena Elez, Eric Van Cutsem, et al.
Lancet (London, England)
|
January 28, 2025
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
Thierry André, Elena Elez, Heinz-Josef Lenz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2024
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study
Natasha B Leighl, Hiroaki Akamatsu, Sun Min Lim, et al.
Page
of 14